// App-Quantinova.ai

1109 : Targeted Next Generation Sequencing Improves Diagnosis in Unclassifiable Leukemic Indolent B-Cell Non-Hodgkin Lymphoma and Identifies a Subset with Recurrent MYD88 Mutations in a Prospective Multicentre Study

Researchers

Presenter

  • Matthew J Cross

Principal Investigators

  • Grzegorz Pietka

  • Sarah Dunne

  • Leonora Conneely

  • Michael Hubank

  • Corinne De Lord

  • Michelle Furtado

  • Pawel Kaczmarek

  • Dima El-Sharkawi

  • Claire E. Dearden

  • Kabir Mohammed

  • Alan Stewart Dunlop

  • Ricardo Morilla

  • Karol Pal

  • Nikos Darzentas

  • David Gonzalez

  • Dorte Wren

  • Sunil Iyengar

Medical Centers

  • Department of Virology, Royal Free Hospital, London, United Kingdom

  • Clinical Genomics, The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom

  • Department of Virology, Royal Free Hospital, London, United Kingdom

  • Clinical Genomics, The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom

  • Epsom and St Helier University Hospitals NHS Trust, Epsom, United Kingdom

  • Royal Cornwall Hospital, Truro, United Kingdom

  • Department of Haematology, Surrey and Sussex Healthcare NHS Trust, Redhill, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Immunophenotyping, Royal Marsden Hospital, Sutton, United Kingdom

  • Immunophenotyping, Royal Marsden Hospital, Sutton, United Kingdom

  • Department of Molecular Medicine, CEITEC MU - Central European Institute of Technology, Masaryk University, Brno, Czech Republic

  • Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany

  • Movember FASTMAN Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.

Locations

  • United Kingdom

  • Czech Republic

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • B-Cell Non-Hodgkin Lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A